Medical University Of Warsaw — Sponsor Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

5 Recruiting

5 Completed trials

1 Countries active

20 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III: 4 Phase II: 4 Phase III/IV: 1 Phase IV: 1 Phase I: 1 Phase I (FiH): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

5 of 5 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Myocarditis 1 Type 1 diabetes mellitus 1 Neonatal respiratory failure 1

Top IMPs

BUDESONIDE 2 PREDNISONE 2 ALLOGENIC ADIPOSE-TISSUE-DERIVED MESENCHYMAL STEM CELLS 1 AZATHIOPRINE 1 BORTEZOMIB 1 CRIZOTINIB 1 CYCLOPHOSPHAMIDE 1 CYCLOPHOSPHAMIDE MONOHYDRATE 1 DARATUMUMAB 1 DEXAMETHASONE 1 DEXAMETHASONE PHOSPHATE 1 FENOFIBRATE MICRONISED 1

All trials

12 total

Evaluation of the efficacy and safety of prolonged-release budesonide in children with primary IgA nephropathy. Pending

2024-518759-45-00 Phase III 1 country BUDESONIDE; PREDNISONE
Augmenting ischemia-induced vasculo- and angiogenesis after endovascular reperfusion with host-extracted, percutaneously introduced, leucocy… Recruiting

2024-518657-42-00 Phase I 1 country FIBRIN
Phase 2a non-commercial and non-randomized intervention study evaluating the efficacy of crizotinib in the treatment of children with severe… Recruiting

2024-516607-16-00 Phase II 1 country CRIZOTINIB
Study to evaluate the efficacy of immunosuppression (drugs that suppres natural immunologic response of the human body) in treatment of pati… Recruiting

2024-517484-23-00 Phase IV 1 country AZATHIOPRINE; PREDNISONE
ESONIA - The evaluation of efficacy and safety of Nebivolol in the treatment of arterial hypertension in adolescents. Recruiting

2024-518622-32-00 Phase III 1 country NEBIVOLOL HYDROCHLORIDE
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure Recruiting

2024-518685-27-00 Phase III 1 country
Evaluation of the safety and efficacy of an advanced therapy medicinal product containing live ASCs in the treatment of diabetic foot syndro… Ended

2024-518533-29-00 Phase II 1 country ALLOGENIC ADIPOSE-TISSUE-DERIVED MESENCHYMAL STEM CELLS
Phase II, Multicenter Study to Assess Safety and Efficacy of Combination of Sargramostim with D-VCd Therapy (Daratumumab, Cyclophosphamide, … Ended

2024-518658-18-00 Phase II 1 country BORTEZOMIB; CYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE MONOHYDRATE; DARATUMUMAB; DEXAMET…
Application of antiCD19 CAR T lymphocytes for the treatment of adult patients with B-cell acute lymphoblastic leukemia with resistance, rela… Halted

2024-519808-27-00 Phase I (FiH) 1 country TISAGENLECLEUCEL
Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and… Ended

2024-519269-23-00 Phase III 1 country BUDESONIDE; OMEPRAZOLE
Evaluation of the effect of phenofibrate on the functions of beta cells in children with new diagnosis of type 1 diabetes Ended

2024-517483-34-00 Phase II 1 country FENOFIBRATE MICRONISED
Evaluation of frequency occurrence persistent pulmonary hypertension of newborns treated by salbutamol Ended

2024-515216-46-00 Phase III/IV 1 country SODIUM CHLORIDE

Showing 1–12 of 12 trials

← All sponsors A–Z